Form 4: Rocket Pharmaceuticals CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO of Rocket Pharmaceuticals, Gaurav Shah, sold shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- Gaurav Shah, CEO of Rocket Pharmaceuticals, sold 3,621 shares of common stock on May 16, 2025, at a price of $6.528 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Shah directly owns 789,059 shares of Rocket Pharmaceuticals common stock.
- Shah also indirectly owns 207,897 shares through his spouse and 198,341 shares through the Gaurav D. Shah Irrevocable Trust.
Sentiment
Score: 6
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations, with no indication of a change in the executive's overall confidence in the company.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook on the company's future, especially when it's explicitly stated to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/16/2025 | Date of the stock sale transaction. |
| 05/20/2025 | Date of signature on the Form 4 filing. |
Keywords
Rocket Pharmaceuticals, Gaurav Shah, stock sale, Form 4, CEO, RSUs, tax obligations, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.